How do I identify pulmonary nodules on a high‑resolution CT (HRCT) of the thorax?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Identifying Pulmonary Nodules on HRCT Thorax

To identify pulmonary nodules on HRCT, you must first ensure proper imaging technique with thin-section CT (≤1.5 mm, typically 1.0 mm slices) with multiplanar reconstructions, then systematically search for focal non-linear opacities on lung windows, characterizing each nodule by size, attenuation (solid vs. subsolid), calcification pattern, margins, and location. 1

Essential Technical Requirements

Optimal imaging technique is critical for accurate nodule detection:

  • Acquire contiguous thin sections ≤1.5 mm (typically 1.0 mm) to enable accurate characterization of small nodules and prevent volume averaging that obscures part-solid morphology and calcification patterns 1
  • Reconstruct and archive coronal and sagittal series to facilitate distinction between true nodules and scars, and to improve detection of juxtapleural nodules 1
  • Use high-resolution algorithm reconstruction with targeted field of view (9.6-10 cm) for maximum spatial resolution 1
  • View images on both lung windows and mediastinal (soft-tissue) windows to assess nodule attenuation and internal characteristics 1
  • Apply sharp (edge-enhancing) filters when evaluating lung windows to better assess solid components in subsolid nodules 1

Common pitfall: Thick sections (≥5 mm) effectively preclude accurate characterization of small nodules and may cause you to miss part-solid components or calcification patterns 1

Systematic Nodule Detection Approach

Define what constitutes a nodule:

  • A nodule appears as a focal non-linear opacity that can be solid or subsolid (ground-glass opacity) 1
  • Measure nodule diameter as the average of length and width, rounded to the nearest millimeter 1
  • Distinguish nodules from blood vessels by following structures through multiple slices—vessels branch and connect, while nodules remain discrete 1

Nodule Characterization by Attenuation

Categorize each nodule by attenuation pattern:

Solid Nodules

  • Completely obscure the underlying lung parenchyma on thin-section images 1
  • Remain visible on mediastinal window settings 1

Ground-Glass Nodules

  • Appear as hazy increased opacity that does NOT completely obscure lung parenchyma 1
  • Vessels and bronchi remain visible through the nodule 1
  • Become partially or completely invisible on mediastinal window settings 1

Part-Solid Nodules

  • Contain both solid and ground-glass components 1
  • Have patches that completely obscure lung parenchyma (solid) mixed with areas where parenchyma remains visible (ground-glass) 1
  • Blood vessels within the nodule appear as solid components but should not be counted as such when distinguishing part-solid from pure ground-glass 1

Critical caveat: Subjective classification of nodules as solid versus subsolid shows high inter- and intraobserver variability—correct classification by all radiologists occurs in only 58% of cases, so use mediastinal windows with sharp filters to objectively assess solid components 1

Calcification Pattern Assessment

Identify benign calcification patterns that require no follow-up:

  • Diffuse (complete) calcification: uniform distribution throughout the entire nodule 1, 2
  • Central calcification: dense calcification in the center, typical of healed granulomas 1, 2
  • Laminated (concentric) calcification: appearing in layers like tree rings, characteristic of granulomas 1, 2
  • "Popcorn" calcification: irregular chunky pattern typical of hamartomas 1, 2
  • Macroscopic fat: indicates benign hamartoma 1, 2

Critical warning: Eccentric, stippled, or amorphous calcification does NOT indicate benignity and can occur in carcinomas, osteosarcomas, chondrosarcomas, and metastases 2

Technical requirement: Assess calcification on images reconstructed without edge-enhancing filters, and view on both bone and lung windows for nodules <5 mm 1, 2

Nodule Margin and Morphology Assessment

Evaluate margin characteristics that affect malignancy risk:

  • Spiculated (irregular, radiating) margins increase malignancy probability with odds ratio 2.2-2.5 1, 3
  • Lobulated margins are suspicious, particularly in part-solid nodules 1
  • Smooth margins are more common in benign lesions but do not exclude malignancy 3

Assess special morphologic features:

  • Cystic components within part-solid nodules are highly suspicious for adenocarcinoma 1
  • Perifissural location with triangular/oval shape suggests benign intrapulmonary lymph nodes 2, 3

Location Documentation

Document nodule location systematically:

  • Upper lobe location is a risk factor for malignancy that may warrant closer surveillance 1, 2
  • Perilymphatic distribution (peribronchovascular, septal, subpleural) suggests sarcoidosis, lymphangitic carcinomatosis, or pneumoconiosis 4
  • Centrilobular distribution suggests infectious/inflammatory etiology or pneumoconiosis 4

Size Measurement Protocol

Measure nodules accurately for management decisions:

  • Use electronic calipers to measure average of long and short axes 1
  • Round measurements to nearest millimeter 1
  • Consider volumetric measurement (volume threshold 100-250 mm³) for more reproducible serial assessment, though this is software-dependent 5
  • Ensure entire nodule is captured by obtaining images well above and below the nodule when performing targeted HRCT 1

Multiple Nodule Assessment

When multiple nodules are present:

  • Document the six largest nodules if more than six noncalcified nodules are present 1
  • Use the most suspicious nodule to guide management when multiple nodules of varying sizes exist 1
  • Consider multifocal adenocarcinoma when multiple subsolid nodules are present, particularly if at least one is part-solid with suspicious features 1

What NOT to Do

  • Do not rely on chest radiography for nodule detection or follow-up, as sensitivity is poor and most nodules <1 cm are not visible 2, 5
  • Do not use intravenous contrast for initial nodule identification or characterization, as it adds no value and unnecessary risk 1, 2, 5
  • Do not assume any calcification indicates benignity—only the four classic benign patterns (diffuse, central, laminated, popcorn) are definitively benign 2
  • Do not evaluate nodules on thick-section CT (≥5 mm)—this precludes accurate characterization and may miss small nodules entirely 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pulmonary Nodule Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

CT Chest Without Contrast for Lung Nodule Follow-Up

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.